Nutrition and physical activity during and after cancer treatment: An American Cancer Society Guide for informed choices

Ca-A Cancer Journal for Clinicians

Volumn 53, Issue 5, 2003, Pages 268-291

  Brown, Jean K ^a   Byers, Tim ^b   Doyle, Colleen ^c   Courneya, Kerry S ^d   Demark Wahnefried, Wendy ^e   Kushi, Lawrence H ^f   McTiernan, Anne ^g   Rock, Cheryl L ^h   Aziz, Noreen ⁱ   Bloch, Abby S ^j   Eldridge, Barbara ^j   Hamilton, Kathryn ^j   Katzin, Carolyn ^j   Koonce, Amy ^j   Main, Julie ^j   Mobley, Connie ^j   Morra, Marion E ^j   Pierce, Margaret S ^j   Sawyer, Kimberly Andrews ^j  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f DIVISION OF RESEARCH   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BLACK TEA EXTRACT; CALCIUM; CATECHIN; FOLIC ACID; GARLIC EXTRACT; GINGER EXTRACT; GREEN TEA EXTRACT; ISOFLAVONE DERIVATIVE; LIGNAN; LINSEED OIL; LYCOPENE; MEGESTROL ACETATE; MELATONIN; METHOTREXATE; MINERAL; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PHYTOESTROGEN; POLYPHENOL; SELENIUM; UNINDEXED DRUG; VITAMIN D; WARFARIN;

ADVANCED CANCER; ALTERNATIVE MEDICINE; BODY WEIGHT; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; DIGESTIVE SYSTEM CANCER; DRUG MECHANISM; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MOTIVATION; NAUSEA; NUTRITION; NUTRITIONAL SUPPORT; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SKIN CANCER; STOMACH PAIN; THROMBOCYTE DYSFUNCTION; TREATMENT OUTCOME; VOMITING;

EID: 0142070780     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.53.5.268     Document Type: Review

References (149)

1. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003. Web site: http://seer.cancer.gov/csr/1975-2000
2. Brown J, Byers T, Thompson K, et al. Nutrition during and after cancer treatment: A guide for informed choices by cancer survivors. CA Cancer J Clin 2001;51:153-187.
3. Shils ME, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams & Wilkins; 1999.
4. McMahon K, Brown JK. Nutritional screening, assessment, and planning for patients receiving cancer treatment. Semin Oncol Nurs 2000; 16:106-112.
5. Monsen ER. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc 2000; 100:637-640.
6. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000.
7. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1997.
8. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press, 1998.
9. Labriloa D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999;13:1003-1008.
10. Lamson D, Brignall M. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999;4:304-329.
11. Prasad K, Kumar A, Kochupillai V, Cole W. High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 1999; 18:13-25.
12. Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour in patients with poor clinical status. Eur J Cancer 1999;35:1688-1692.
13. Ghielmini M, Pagani O, deJong J, et al. Double-blind randomized study on the myelo-protective effect of melatonin in combination with carboplatin and etoposide in advancer lung cancer. Br J Cancer 1999;80:1058-1061.
14. Courneya KS. Exercise in cancer survivors: An overview of research. Med Sci Sports Exerc. 2003. In press.
15. Friedenreich CM. Physical activity and cancer prevention: From observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001;10:287-301.
16. Byers T, Nestle M, McTiernan A, et al. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2002;52:92-119.
17. USDA Dietary Guidelines for Americans, 5th ed., 2000. Rockville, MD: US Dept of Health and Human Services; 2000. Home and Garden Bulletin No. 232:239.
18. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997.
19. World Health Organization. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. Geneva, Switzerland: WHO, 2003. WHO technical report series 916.
20. Krauss RM, Eckel RH, Howard B, et al. American Heart Association Dietary Guidelines: Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000; 102:2284-2299.
21. International Agency for Research on Cancer. Weight control and physical activity. IARC Handbooks of Cancer Prevention, volume 6. Lyon, France: IARC Press, 2002.
22. Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, 1996.
23. Gagnon G, Bruera E. A review of the drug treatment of cachexia associated with cancer. Drugs 1998;55:675-678.
24. Goldberg RM, Loprinzi CL. Cancer anorexia/cachexia. In von Gunten CF, ed. Palliative care and rehabilitation of cancer patients. Boston: Klewer Academic, 1999;31-41.
25. Maltoni M, Nanni O, Scarpi E, et al. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: A systematic review of randomized clinical trials. Ann Oncol 2001;12: 289-300.
26. Brown JK. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncol Nurs Forum 2002;29:517-530.
27. Beckett DM. Rethinking nutritional support for persons with cancer cachexia: A call for research to evaluate the effects of nutraceuticals. Biological Research in Nursing. In press.
28. Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachesia: A double-blind, placebo-controlled study. J Clin Oncol 2003;21:129-134.
29. American Society for Parenteral and Enteral Nutrition. National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition. Safe practices for parenteral nutrition formulations. Journal of Parenteral and Enteral Nutrition 1998;22:49-66.
30. American Dietetic Association . Ethical and legal issues in nutrition, hydration, and feeding. J Am Diet Assoc 2002;102:716-726.
31. Mokdad A, Ford E, Bowman B, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79.
32. Tartter PI, Slater G, Papatestas AE, Aufses AH. Cholesterol, weight, height, Quetelet's index, and colon cancer recurrence. J Surg Oncol 1984;27:232-235.
33. Slattery ML, Anderson K, Samowitz W, et al. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer. Cancer Causes Control 1999;10:467-473.
34. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 2002;20: 3302-3316.
35. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-1143.
36. Calle EE, Rodriquez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-1638.
37. Camoriano JK, Loprinzi CL, Ingle JN, et al. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 1990; 8:1327-1334.
38. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 1997;97:519-529.
39. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998; 68:899-917.
40. Cummings S, Parham ES, Strain GW. Position of the American Dietetic Association: Weight management. J Am Diet Assoc 2002;102: 1145-1155.
41. Hunter D, Willett W. Nutrition and breast cancer. Cancer Causes Control 1996;7:56-68.
42. Smith-Warner S, Spiegelman D, Adami H, et al. Types of dietary fat and breast cancer: A pooled analysis of cohort studies. Int J Cancer 2001;92:767-774.
43. Kushi L, Giovannucci E. Dietary fat and cancer. Am J Med 2002;113:63S-70S.
44. Meyer F, Bairati I, Shadmani R, et al. Dietary fat and prostate cancer survival. Cancer Causes Control 1999;10:245-251.
45. Kim DJ, Gallagher RP, Hislop TG, et al. Premorbid diet in relation to survival from prostate cancer (Canada). Cancer Causes Control 2000;11:65-77.
46. Chlebowski R, Blackburn G, Buzzard I, et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol 1993; 11:2072-2080.
47. Pierce JP, Faerber S, Wright F, et al. A randomized trial of the effect of a plant based dietary pattern on breast cancer recurrence: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials 2002;23:728-756.
48. Gogos CA, Ginopoulos P, et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: A randomized control trial. Cancer 1998; 82:395-402.
49. Sabate J, Ratzin-Turner R, eds. Vegetarian Nutrition. Boca Raton, FL: CRC Press, 2001.
50. Moe GL. Low-microbial diets for patients with granulocytopenia. In: Bloch AS, ed. Nutrition Management of the Cancer Patient. Rockville, MD: Aspen Publishers; 1990:125.
51. Colditz G, DeJong W, Hunter D, et al., eds. Harvard Report on Cancer Prevention, Vol. 1. Causes of Human Cancer. Cancer Causes Control 1996;7(Suppl).
52. World Cancer Research Fund in association with American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: World Cancer Research Fund, 1997.
53. Rimm E. Alcohol and cardiovascular disease. Curr Atheroscler Rep 2000;2:529-535.
54. Smith-Warner SA, Spiegelman D, Yuan SS, et al. Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA 1998; 279:535-540.
55. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA 1998;280:1569-1575.
56. Newman V, Rock C, Faerber S, et al. Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. J Am Diet Assoc 1998; 98:285-292.
57. Willett W, Stampfer M. What vitamins should I be taking, doctor? N Engl J Med 2001; 345:1819-1824.
58. Fletcher R, Fairfield K. Vitamins for chronic disease prevention in adults: Clinical applications. JAMA 2002;287:3127-3129.
59. The Alpha Tocopherol, Betacarotene Prevention Study Group. The effect of vitamin E and betacarotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035.
60. Omenn G, Goodman G, Thornquist M, et al. Effects of a combination of betacarotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-1155.
61. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control 1996;7:157-177.
62. Baron JA, Cole BF, Mott L, et al. Neoplastic and antineoplastic effects of B-carotene on colorectal adenoma recurrence: Results of a randomized trial. J Natl Cancer Inst 2003;95:717-722.
63. Irwin M, Crumley D, McTiernan A, et al. Physical activity levels before and after a diagnosis of breast cancer: The Health, Eating, Activity, and Lifestyle (HEAL) Study. Cancer 2003;97: 1746-1757.
64. Courneya KS, Friedenreich CM. Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. J Altern Complement Med 1997;3:215-226.
65. Courneya KS, Friedenreich CM. Relationship between exercise during treatment and current quality of life among survivors of breast cancer. J Psychosoc Oncol 1997;15:35-57.
66. Courneya KS, Friedenreich CM. Framework PEACE: An organizational model for examining physical exercise across the cancer experience. Ann Behav Med 2001;23:263-272.
67. Saarto T, Blomquist C, Valimaki M, et al. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluourouracil chemotherapy causes rapid bone loss that is reduced by clodronate: A randomized study in premenopausal breast cancer patients. J Clin Oncol 1997;15:1341-1347.
68. Smith MR. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma. Cancer 2003;97:789-795.
69. McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: A pilot study. J Clin Oncol 2003;21:463-466.
70. Harris SR, Nieses-Vertommen SL. Challenging the myth of exercise-induced lymphedema following breast cancer: A series of case reports. J Surg Oncol 2000;74:95-99.
71. Nieman DC. Is infection risk linked to exercise workload? Med Sci Sports Exerc 2000;32: S406-S411.
72. Cassileth BR. The Alternative Medicine Handbook. New York: WW Norton; 1998.
73. Green S. A critique of the rationale for cancer treatment with coffee enemas and diet. JAMA 1992;268:3224-3227.
74. National Institutes of Health: Alternative Medicine: Expanding Medical Horizons: A Report to the National Institutes of Health on Alternative Medical Systems and Practices in the United States. Washington, DC:US Government Printing Office, 1995. NIH Publication No. 94-066.
75. Gonzalez NJ, Isaacs LL. Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer 1999;33:117-124.
76. Phase III Study of Gemcitabine Versus Intensive Pancreatic Proteolytic Enzyme Therapy With Ancillary Nutritional Support (Gonzalez Regimen) in Patients With Stage II, III, or IV Adenocarcinoma of the Pancreas. Protocol ID CPMC-IRB-8544. Web site: http://www.cancer.gov/ClinicalTrials/
77. American Cancer Society. Unproven methods of cancer management. Livingston-Wheeler therapy. CA Cancer J Clin 1991;41:17-22.
78. Cassileth BR, Lusk EJ, Guerry D, et al. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991;324:1180-1185.
79. Kushi L, Cunningham J, Hebert J, et al. The macrobiotic diet in cancer. J Nutr 2110;131: 3056s-3064s.
80. Chen J, Stavro PM, Thompson LU. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulated expression of insulin-like growth factor and epidermal growth factor receptor. Nutrition and Cancer 2002;43: 187-192.
81. Dabrosin C, Chen J, Wang L, Thompson LU. Flaxseed inhibits metastasis and decreases extracellular vascular endometrial growth factor in human breast cancer xenografts. Cancer Lett 2002; 185:31-37.
82. Demark-Wahnefried W, Price DT, Polascik TJ, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormone levels, prostate-specific antigen and histopathologic features. Urology 2001;58:47-52.
83. Fleischauer AT, Arab L. Garlic and cancer: A critical review of the epidemiologic literature. J Nutr 2001;131:1032S-1040S.
84. University of Texas M. D. Anderson Cancer Center. Herbal/Plant Therapies: Ginger (Zingiber officinale Roscoe) Natural Standard Patient Monograph, 2002. Web site: http://www.mdanderson. org/departments/CIMER, accessed 6/06/03.
85. Miller LG. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200-2211.
86. Bushman J. Green tea and cancer in humans: A review of the literature. Nutr Cancer 1998;31: 151-159.
87. Dufresne CJ, Farnworth ER. A review of latest research findings on the health promotion properties of tea. J Nutr Biochem 2001;12:404-421.
88. Weisburger J. Tea and health: The underlying mechanisms. Proc Soc Exp Biol Med 1999;220: 271-275.
89. Jatoi A, Ellison N, Burch PA, et al. A phase II trial of green tea in the treatment of patients with androgen dependent metastatic prostate carcinoma. Cancer 2003;97:1442-1446.
90. Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council; 1998.
91. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: A critical review of the evidence. Breast Cancer Res Treat 1990;16:205-214.
92. Tretli S, Haldorsen T, Ottestad L. The effect of pre-morbid height and weight on the survival of breast cancer patients. Br J Cancer 1990;62: 299-303.
93. Demark-Wahnefried W, Kenyon AJ, Eberle P, et al. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: Results of a feasibility study. Clin Exerc Physiol 2002;4:44-49.
94. Goodwin P, Esplen MJ, Butler K, et al. Multidisciplinary weight management in locoregional breast cancer: results of a phase II study. Breast Cancer Res Treat 1998;48:53-64.
95. McTiernan A, Ulrich C, Kumai C, et al. Anthropometric and hormone effects of an eight-week exercise-diet intervention in breast cancer patients: Results of a pilot study. Cancer Epidemiol Biomarkers Prev 1998;7:477-481.
96. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst 1993;85:979-997.
97. Wingo PA, Ries LA, Parker SL, Heath CW Jr. Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev 1998;7:271-282.
98. Aslani A, Smith RC, Allen BJ, et al. Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat 1999;57:285-290.
99. Cheney CL, Mahloch J, Freeny P. Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr 1997;66: 141-146.
100. Demark-Wahnefreid W, Hars V, Conaway M, et al. Reduced rates of metabolism and decreased activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr 1997; 65:1495-1501.
101. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001;19:2381-2389.
102. McTiernan A, Ulrich C, Slate S, Potter J. Physical activity and cancer etiology: Associations and mechanisms. Cancer Causes Control 1998;9: 487-509.
103. Irwin M, Yasui Y, Ulrich CM, et al. Effect of moderate- and vigorous-intensity exercise on total and intra-abdominal body fat in postmenopausal women: A one-year randomized controlled trial. JAMA 2003;289:323-333.
104. Gandini S, Merzenich H, Robertson C, Boyle P. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 2000;36:636-646.
105. Smith-Warner SA, Spiegelman D, Yaun SS, et al. Intake of fruits and vegetables and risk of breast cancer: A pooled analysis of cohort studies. JAMA 2001;285:769-776.
106. Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake and the risk of breast cancer. JAMA 1999;281:1632-1637.
107. Rohan TE, Jain MG, Howe GR, Miller AB. Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 2000;92:266-269.
108. Sellers TA, Kushi LH, Cerhan JR, et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 2001;12:420-428.
109. Feigelson HS, Jonas CR, Robertson AS, et al. Alcohol, folate, methionine, and risk of incident breast cancer in the American Cancer Society Cancer Prevention Study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2003;12:161-164.
110. Zhang S, Willett W, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 2003;95:373-380.
111. Messina M, Loprinzi C. Soy for breast cancer survivors: A critical review of the literature. J Nutr 2001;131:3095s-3108s.
112. Kris-Etherton P, Hecker K, Bonanome A, et al. Bioactive compounds in foods: Their role in prevention of cardiovascular disease and cancer. Am J Med 2002;113:71s-88s.
113. Peeters P, Keinan-Boker L, van der Schouw Y, Grobbee D. Phytoestrogens and breast cancer risk. Review of the epidemiologic evidence. Breast Cancer Res Treat 2003;77:171-183.
114. Petrakis N, Barnes S, King E, et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and post-menopausal women. Cancer Epidemiol Biomarkers Prev 1996;10:785-794.
115. Potter J. Nutrition and colorectal cancer. Cancer Causes Control 1996;7:127-146.
116. Byers T. What can randomized controlled trials tell us about nutrition and cancer prevention?. CA Cancer J Clin 1999;49:353-361.
117. Baron J, Beach M, Mandel J, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999;340:101-107.
118. Courneya KS, Friedenreich CM, Arthur K, Bobick TM. Physical exercise and quality of life in post-surgical colorectal cancer patients. Psychol Health Med 1999;4:181-187.
119. Courneya K, Friedenreich CM, Quinney HA, et al. A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care. In press.
120. Clark LC, Coombs GF Jr., Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. National Prevention of Cancer Study Group. JAMA 1996;276: 1957-1963.
121. Phase III Randomized Chemoprevention Study of Selenium in Participants With Previously Resected Stage I Non-Small Cell Lung Cancer (Protocol ID E-5597). Web site: http://www.cancer.gov/ClinicalTrials/
122. Sun AS, Ostadal O, Ryznar V, et al. Phase I/II study of stage III and IV non-small cell lung cancer patients taking a specific dietary supplement. Nutr Cancer 1999;34:62-69.
123. Sun AS, Yeh HC, Wang LH, et al. Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients. Nutr Cancer 2001;39: 85-95.
124. Evans WK, Nixon DW, Daly JM, et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small cell lung cancer. J Clin Oncol 1987;5:113-124.
125. Ovesen L, Allingstrup L. Different quantities of two commercial liquid diets consumed by weight-losing cancer patients. Journal of Parenteral and Enteral Nutrition 1992;16:275-278.
126. Ovensen L, Allingstrup L, Hannibal J, et al. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: A prospective, randomized study. J Clin Oncol 1993;11:2043-2049.
127. Kolonel L, Nomura A, Cooney R. Dietary fat and prostate cancer: current status. J Natl Cancer Inst 1999;91:414-428.
128. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000;92:61-68.
129. Meyer F, Bairati I, Shadmani R, et al. Dietary fat and prostate cancer survival. Cancer Causes Control 1999;10:245-251.
130. Kim DJ, Gallagher RP, Hislop TG, et al. Premorbid diet in relation to survival from prostate cancer (Canada). Cancer Causes Control 2000;11:65-77.
131. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999; 91:317-331.
132. Miller EC, Hadley CW, Schwartz SJ, et al. Lycopene, tomato products, and prostate cancer prevention. Have we established causality? Pure Applied Chemistry 2002;74:1435-1441.
133. Kucuk O, Sarkar FH, Sakr W, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001;10:861-868.
134. Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001;93:1872-1879.
135. Giovannucci E, Rimm E, Wolk A, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998;58:442-447.
136. Beer TM, Lemmon D, Lowe BA, Henner WD. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer 2003;97:1217-1224.
137. Beer TM, Eilers KM, Garzotto M, et al. Weekly high-dose calcitriol and docetaxel in metastatic androgen-dependent prostate cancer (comment). J Clin Oncol 2003;21:123-128.
138. Heininen Olli P, et al. Prostate cancer and supplementation with alpha-tocoperol and beta-carotene: Incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-446.
139. Clark L, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 1998;81:730-734.
140. Phase III Randomized Study of Selenium and Vitamin E for the Prevention of Prostate Cancer (SELECT Trial) (Protocol ID SWOG-50000). Web site: http://www.cancer. gov/ClinicalTrials/
141. Phase II Pilot Randomized Study of Selenium Versus Observation Only Before Radical Prostatectomy in Patients with Primary Adenocarcinoma of the Prostate (Protocol ID SWOG-S9812). Web site: http://www.cancer. gov/ClinicalTrials/
142. Chen H, Miller BA, Giovannucci E, Hayes RB. Height and the survival of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2003;12:215-218.
143. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003;21:1653-1659.
144. Marshall JR, Boyle P. Nutrition and oral cancer. Cancer Causes Control 1996;7:101-112.
145. Cheng KK, Day NE. Nutrition and esophageal cancer. Cancer Causes Control 1996;7:33-40.
146. Kono S, Hirohata T. Nutrition and stomach cancer. Cancer Causes Control 1996;7:41-55.
147. Michaud DS, Giovannucci E, Willett WC, et al. Physical activity, obesity, height and the risk of pancreatic cancer. JAMA 2001;286: 921-929.
148. Mayne S, Cartmel B, Baum M, et al. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. Cancer Res 2001;61:1457-1463.
149. Carter JP, Saxe GP, Newbold V, et al. Hypothesis: dietary management may improve survival from nutritionally linked cancers based on analysis of representative cases. J Am Coll Nutr 1993;12:209-226.